Shanghai MicroPort MedBot (Group) (HKG:2252) recorded a cumulative order volume of over 100 units for the laparoscopic, orthopedic, and vascular interventional core products of the group for 2024, a Friday Hong Kong bourse filing said.
39 orders were received for Toumai Laparoscopic Surgical Robot, while SkyWalker Orthopedic Surgical Robot saw an order volume of 25 units in 2024.
Moreover, R-ONE Vascular Interventional Surgical Robot won purchase order bids from five top public hospitals in Shanghai, the filing said.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。